. Author manuscript; available in PMC: 2008 Feb 25.

Published in final edited form as: J Neuropathol Exp Neurol. 2007 Jan;66(1):75–85. doi: 10.1097/nen.0b013e31802d6da9

TABLE 3.

The Number of Cases Exhibiting Nuclear or Cytoplasmic Nuclear Factor E2-Related Factor 2 Staining in Neurons of Parkinson Disease, Two Diagnostic Categories of Alzheimer Disease, or Age-Matched Controls

	Hippocampus		Substantia Nigra
Diagnosis	Nuclear	Cytoplasmic	Nuclear	Cytoplasmic
Control	5/5	5/5	0/5	5/5
AD	1/12^*	12/12	0/8	8/8
LBVAD	0/3^†	3/3	0/3	3/3
PD	5/5	5/5	5/5^*	5/5

The fraction of cases exhibiting nuclear or cytoplasmic nuclear factor e2-related factor 2 staining in hippocampus and substantia nigra among 3 diagnostic groups: age-matched control (control), Alzheimer disease (AD), Lewy body variant of Alzheimer disease (LBVAD), and Parkinson disease (PD).

Indicates significantly different from control (p < 0.01) using the Fisher exact test.

^†

Indicates significantly different from control (p < 0.05).